NewslettersHepatic Cell NewsDNASE1L3 Inhibits Hepatocellular Carcinoma by Delaying Cell Cycle Progression through CDK2By lbeveridge - November 4, 20220301Investigators found that DNASE1L3 was significantly downregulated and served as a favorable prognostic factor in HCC.[Cellular Oncology]Abstract